Loading company…
UXN develops blood glucose monitoring sensors and related measurement technology.
Founded in 2012 and based in Suwon, South Korea, UXN develops blood glucose monitoring solutions. Its AGMS sensors use mesoporous platinum instead of glucose-sensitive enzymes and are designed for people with type 1 or type 2 diabetes. In October 2021, SD Biosensor, Inc. invested KRW 20 billion for a 22.33% minority stake.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in